NCCH2006/MK010 Trial (FORTUNE Trial) — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(7 sites)
Japan
National Cancer Center Hospital, Chuo-ku, Tokyo, Japan Kanagawa Cancer Center, Yokohama, Kanagawa Tohoku University Hospital, Aoba-ku, Sendai, Miyagi Kyushu University Hospital, Higashi-Ku, Fukuoka Hokkaido University Hospital, Kita-Ku, Sapporo, Hokkaido Okayama University Hospital, Okayama Kyoto University Hospital, Sakyo-ku, Kyoto Last updated October 2025